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Abstract
Background: Opioid receptors and endogenous opioid peptides act not only in the control of nociceptive pathways, 
indeed several reports demonstrate the effects of opiates on sperm cell motility and morphology suggesting the 
importance of these receptors in the modulation of reproduction in mammals. In this study we investigated the 
expression of delta opioid receptors on equine spermatozoa by western blot/indirect immunofluorescence and its 
relationship with sperm cell physiology.
Methods: We analyzed viability, motility, capacitation, acrosome reaction and mitochondrial activity in the presence of 
naltrindole and DPDPE by means of a computer assisted sperm analyzer and a fluorescent confocal microscope. The 
evaluation of viability, capacitation and acrosome reaction was carried out by the double CTC/Hoechst staining, 
whereas mitochondrial activity was assessed by means of MitoTracker Orange dye.
Results: We showed that in equine sperm cells, delta opioid receptor is expressed as a doublet of 65 and 50 kDa 
molecular mass and is localized in the mid piece of tail; we also demonstrated that naltrindole, a delta opioid receptor 
antagonist, could be utilized in modulating several physiological parameters of the equine spermatozoon in a dose-
dependent way. We also found that low concentrations of the antagonist increase sperm motility whereas high 
concentrations show the opposite effect. Moreover low concentrations hamper capacitation, acrosome reaction and 
viability even if the percentage of cells with active mitochondria seems to be increased; the opposite effect is exerted 
at high concentrations. We have also observed that the delta opioid receptor agonist DPDPE is scarcely involved in 
affecting the same parameters at the employed concentrations.
Conclusions: The results described in this paper add new important details in the comprehension of the mammalian 
sperm physiology and suggest new insights for improving reproduction and for optimizing equine breeding.
Background
Opioid receptors and endogenous opioid peptides form a
neuromodulatory system primarily active in the control
of nociceptive pathways. Endogenous opioids act as neu-
rotransmitters in both central and peripheral nervous
s y s t e m  [ 1 ] .  T h e y  w e r e  f o u n d in several other districts
such as adrenal medulla, pancreatic islets, pituitary, intes-
tinal and bronchial mucosa [2] and in reproductive
organs [3-8], thus they seem to be implied in the regula-
tion of nociception, respiration, cardiovascular function,
gastrointestinal motility, mood [9] but also in the modu-
lation of the reproductive activity [10-12].
Opioid receptors are also targets of exogenous narcotic
opiate alkaloids that constitute a major class of drug
abuse [13]. Several reports demonstrate the effects of opi-
ate compounds on sperm cell motility [14-16] and mor-
phology [17] thus suggesting the importance of these
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receptors in the modulation of reproduction in mam-
mals.
Our current understanding on opioid receptors can be
summarized as follows: they belong to the superfamily of
seven transmembrane-spanning G-protein coupled
receptors [18] and can be divided in three major types
named MOR, DOR, KOR (mu, delta, kappa opioid recep-
tors respectively). The opioids/receptor system exhibits
impressive diversity in terms of the number of endoge-
nous ligands (more than a dozen) that converge at the
three major types of receptors [19]. In general, opioids
have been found to inhibit neuronal excitability via two
mechanisms: inhibition of calcium and enhancement of
potassium conductance [20,21], besides, upon activation,
a variety of signal transduction processes are induced
with different mechanisms noticeable in diverse cell types
such as activation of the mitogen-activated protein
(MAP) kinases and the phospholipase C mediated cas-
cade. Moreover, adaptation, which is a consequence of a
prolonged exposure to opiates, can cause the internaliza-
tion of the receptor via a classic endocytic pathway
occurring in a ligand specific manner that is independent
of ligand ability to stimulate G-protein signalling thus
explaining the differences in the efficacy and abuse
potential of various opiates [22].
Molecular cloning identified for DOR, as well as for
MOR and KOR, an unique gene, even if pharmacological
studies indicate the existence of two subtypes for MOR
and DOR [23] and at least four subtypes for KOR [24,25];
the existence of multiple mechanisms to achieve distinct
pharmacological profiles for receptors originated from a
single gene can explain such discrepancy. Even if no
mRNA splicing variants have been detected for DOR,
several variants at protein level have been identified that
are the result of different post translation modifications,
such as homo and hetero dimerization with MOR and
KOR [26], glycosylations [27,28] likely to be responsible
for the appearance of different DOR subtypes [29].
DOR is activated by specific agonists such as cyclo-[D-
Pen2,5]enkephalin (DPDPE) and [D-Ala2, D-Leu5]-
enkephalin (DADLE) and inactivated by selective antago-
nists like naltrindole and Naltriben [30], as well as by non
specific endogenous and synthetic compounds.
DOR has been extensively localized in the central ner-
vous system [31], recently it has been found in human
spermatozoa [12] so that its possible involvement in the
modulation of sperm motility has been hypothesized. On
the other hand it has been demonstrated that sperm cells
express MOR [10-12] and KOR [12] and that the human
semen contains beta-endorphin, an endogenous opioid
peptide [32], Up to now DOR involvement in sperm
motility has not been clearly demonstrated: Agirregoitia
et al. [12] indeed showed that different doses of DPDPE
have no effects on human sperm motility; on the contrary
its antagonist, naltrindole, is effective in reducing sperm
movements.
Aim of this work is to investigate the relationship
between DOR and sperm cell physiology and the possible
involvement of DOR in the modulation of viability, motil-
ity, capacitation, acrosome reaction (AR) and mitochon-
drial activity of equine spermatozoa.
Methods
Chemicals
Unless otherwise stated, were purchased by Sigma-
Aldrich (Milano, Italy), precast Criterion XT gradient 4-
1 2 %  S D S - p o l y a c r y l a m i d e  g e l s  w e r e  f r o m  B i o - R a d
(Milano, Italy).
The fluorescent tripeptide: H-Dmt-Tic-Glu-NH-(CH2)5
-NH-(C = S)-NH-fluorescein, analogue of the delta opi-
oid receptor antagonist Dmt-Tic (Dmt: 2',6'-dimethyl-L-
tyrosine; Tic: 1,2,3,4-tetrahydroisoquinoline-3-carboxy-
lic acid) was kindly provided by Prof. G. Balboni (Depart-
ment of Pharmaceutical Sciences and Biotechnology
Centre and Department of Chemistry, University of Ferr-
ara, Italy).
Animal and semen collection
Gel-free semen was collected in an artificial vagina from
six healthy, mature stallions, age 10-12 years, housed at
the Equine Reproductive Centre "Pegasus" located at the
Faculty of Veterinary Medicine, University of Bari, Italy.
The management and the collection of semen samples
were performed in accordance with health and welfare
regulations in force and approved by the intramural
Department Council of the University of Bari.
Semen concentration and motility were measured by
the computer assisted sperm analyzer (CASA).
After collection, semen was immediately diluted 1:5 in
prewarmed (37°C) Tyrode's medium and washed 3 times
at 900 × g. Sperm cells were finally resuspended in
Tyrode's medium containing albumin, lactate and pyru-
vate (TALP) at 5 × 107 cells/ml concentration.
Western blot analysis
Cell extracts were prepared by ultrasonic disruption of
spermatozoa (8 pulses of 10 sec at 20 kHz, 80 microme-
ters amplitude) in a cold buffer (0.5% Igepal, 0.1% Tween-
20, 8 M Urea, 30 mM N-octyl-β-D-glycopyranoside, 0.5%
Triton X-100, 1% Sodium Dodecyl Sulphate, pH 7.2) con-
taining a protease inhibitors mix (1 mg/ml Pepstatin A, 1
mg/ml Leupeptin, 1 mg/ml Aprotinin, 100 mg/ml Phenyl
methane sulfonyl fluoride, 100 μg/ml Benzamidine, 8 mg/
ml Calpain I and II). After centrifugation (10 min at 5000
× g at 4°C) to remove cell debris, soluble proteins (40 μg/
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transferred by the Trans-Blot semi-dry apparatus (Bio-
Rad) to an Immobilon-P membrane (Millipore, Milan,
Italy). The filter was blocked in 5% not fat dry milk buffer
(20 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 1% (v/v) Triton-
X100), and proteins corresponding to DOR were identi-
fied by the primary antibody (rabbit anti DOR, Chemicon
Inc. Temecula, CA, USA) diluted 1:5000 applied for one
night. After membrane washing, the secondary antibody
(anti rabbit IgG Horseradish Peroxidase conjugated)
diluted 1:10000 was applied for 2 h at room temperature
and immunoreactive bands detected by the enhanced
ECL plus system (Amersham Bioscience, Little Chalfont,
UK). A negative control was obtained incubating the fil-
ter with a solution in which the primary antibody was
absorbed with a molar excess of the immunizing peptide.
Moreover to verify an equal protein loading, membranes
were stripped by Restore™ Western Blot Stripping Buffer
(Thermo Scientific, Rockford, IL, USA) and reprobed
with anti β-actin antibody (Chemicon Inc. Temecula, CA,
USA) diluted 1:10000.
Fluorescence detection of DOR
The localization of DOR on equine spermatozoa was
investigated by means of a highly selective fluorescent tri-
peptide analogue of the potent delta opioid receptor
antagonist Dmt-Tic [33] and by the same rabbit anti DOR
antibody used in the immunoblot detection.
Fluorescent tripeptide
Equine sperm cells, suspended in TALP buffer, were incu-
bated at 37°C for 30 min in the presence of the fluores-
cent tripeptide (0.2 nM). In the negative control
spermatozoa were first incubated for 15 min with naltrin-
dole (0.2 μM) and then were let react with the fluorescent
tripeptide. After incubation sperm cells were fixed in
12.5% glutaraldeide and spotted on a glass slide, mounted
with antifade medium (50% glycerol, 0.5% n-propyl-L-
gallate, 20 mM Tris pH 8.0) and observed for the fluores-
cent pattern by confocal laser scanning microscope C1
(Nikon, Japan) using a 488 nm argon ion and a 543 nm
helium/neon laser.
Anti DOR antibody
Five microliter of sperm cells suspension were smeared
onto Polysine™ slides (Menzel-Gläser GmbH & Co,
Braunschweig, Germany) and let dry to air. Cells were
fixed (4% paraformaldeyde/PBS, 5 min) and slides
washed (100 mM glycine/PBS) and incubated overnight
at 4°C with the same primary antibody (diluted 1:2500 in
1% BSA/PBS) used in the western blot detection. After
washing, the secondary antibody, a fluorescein-labeled
goat anti rabbit antibody (Sigma-Aldrich, Milan, Italy)
diluted 1:200 in Evans Blue/PBS was applied for 2 h at
room temperature. As to control, slides incubated with
5% normal rabbit serum in the absence of the primary
antibody were prepared. Following the washing step, the
slides were mounted with antifade medium as reported
above and observed for the fluorescence pattern with
Nikon Eclipse E600 microscope (Nikon, Japan) equipped
with Nikon Coolpix 990 digital camera.
Computer assisted sperm analysis
The effects of different concentrations of a DOR agonist
DPDPE and antagonist naltrindole, on sperm motility
were analyzed by a Sperm Analyzer (CASA-system;
HTM-IVOS, Version 12.3, Hamilton-Thorne Biosciences,
MA, USA).
Samples containing 50 × 106 cells/ml in TALP medium
were divided in eight aliquots, all of them, except one,
were supplemented with the DOR agonist or antagonist
at the following concentrations: sample 1, control; sample
2-5 (supplemented with naltrindole 10-4 M, 10-5 M, 10-6
M, 10-7 M respectively); samples 6-8 (supplemented with
DPDPE 10-5 M, 10-6 M, 10-7 M respectively) and incu-
bated at 37°C under 5% CO2.
From each experimental condition, at time: 0, 30 min,
90 min, 180 min from the drug addition, 2 μl aliquot was
recovered and placed in a Leja® 4 analysis chamber, 20
micron depth (Leja Products B.V., The Netherlands). The
analysis was conducted at 37°C. The following nine
motility parameters were measured for each sample: the
percentage of motile spermatozoa; the percentage of
spermatozoa with a progressive motility; average path
velocity (VAP): the velocity of the smoothed cell path
(μm/s); straight line velocity (VSL): the average velocity
measured in a straight line from the beginning to the end
of the track (μm/s); curvilinear velocity (VCL): the aver-
age velocity measured over the actual point to point track
followed by the cell (μm/s). The software settings recom-
mended by the manufacturer were adjusted as follows to
obtain a clear identification of the different spermatozoa:
frame rate (Hz) = 60; frames acquired = 45; minimum
contrast = 70; minimum cell size (pixels) = 4; medium
VAP cut-off (μm/s) = 50.0; threshold straightness (%) =
75.0; low VAP cut-off (μm/s) = 20; low VSL cut-off (μm/s)
= 0.0; magnification Optical × 10 = Digital × 1.89; tem-
perature of analysis (°C) = 37; counting Chamber = Leja 4.
Ten randomly selected microscopic fields were scanned.
After every set of scans, the playback mode was used to
analyze the video sequences of the last field, in order to
validate whether all spermatozoa were identified and
their trajectory reconstructed correctly by CASA system.
Capacitation and acrosome reaction
Samples analyzed for motility were also assessed for via-
bility, capacitation and AR by the combined Hoechst
33258/chlortetracycline (CTC) assay in order to verifyAlbrizio et al. Reproductive Biology and Endocrinology 2010, 8:78
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the effects of the different concentrations of DOR ago-
nist/antagonist on the modifications that occur before
and during the exocytic event.
A 198 μl aliquot of each sample was examined after 4.5
h of incubation at 37°C in the presence of 5% CO2, as pre-
viously described [10]. Briefly at each aliquot of sperm
cells suspension, a 2 μl of Hoechst 33258 solution was
added. The Hoechst 33258 solution was made diluting 1
μl of stock solution (10 mg/100 μl distilled water) in 10 ml
of Tyrode's medium. After 2 min of incubation, the dye
excess was removed by a centrifugation at 900 × g for 5
min in the presence of 2% (w/v) polyvinylpyrrolidone
(PVP) in PBS. The cell pellet was resuspended in Tyrode's
medium, an equal volume of CTC solution (0.75 mM
CTC, 5mM L-cysteine in chilled buffer containing 20
mM Tris, 130 mM NaCl, pH 7.8) was added together with
8 μl of 12.5% glutaraldehyde. Four microliter of the
obtained suspension were placed on a slide with a droplet
of antifade and visualized by the Nikon E600 microscope
under epifluorescence illumination using 346-460 nm
(UV-2A) and 450-630 nm (B-3A) excitation/emission fil-
ters for H33258 and CTC respectively. Spermatozoa were
classified as: dead when nuclei showed a bright blue fluo-
rescence over the head; live non capacitated when bright
green fluorescence was distributed uniformly over the
entire sperm head; live capacitated when they showed
green fluorescence over the acrosomal region and a dark
post acrosome; live acrosome reacted when sperm
showed a mottled green fluorescence over the head,
green fluorescence only in the post acrosomal region or
no fluorescence on the head. At least 200 spermatozoa
were scored per slide.
Mitochondrial staining
At the end of the incubation period (4.5 h), an aliquot of
each sperm sample was stained with MitoTracker Orange
CMTM Ros (Molecular Probes M-7510, Oregon, USA) to
evaluate the effects of the different concentrations of
DOR agonist/antagonist on mitochondrial activity.
Briefly, in each sample the cell permeant dye was added
to reach a final concentration of 0.1 μM and let to react at
37°C under 5% CO2 for 30 min. The potentiometric dye is
readily sequestered and become fluorescent after oxida-
tion, a process that only takes place under oxidative respi-
ration. Since this process is only relevant in functional
mitochondria, this probe is suitable to discriminate
sperm with deteriorated mitochondria from aerobically
capable sperm [34,35]. After incubation, sperm cells were
washed 2 times in PBS, centrifuged in the presence of 2%
PVP plus 200 ng of Hoechst 33258 and cell pellet resus-
pended in PBS. Stained cells were spotted on slides and
observed under confocal microscope. Live cells (Hoechst
negative) with active mitochondria were visualized with a
intensively red fluorescence midpiece.
Statistical analysis
Statistical analysis of treatments of spermatozoa with dif-
ferent concentrations of DOR agonist/antagonist was
performed by one way ANOVA or Chi-square test, and p
values of less than 0.05 were considered statistically sig-
nificant.
Results
Western blot analysis
The blot in panel A of figure 1 shows that DOR proteins
are detected as ~65 and 50 kDa bands in equine sperm
cells; the depletion of the antibody by its immune peptide
produces no immunoreactive signals (Fig 1, Panel B). The
same filters reprobed with anti beta-actin antibody show
that equal amounts of proteins were loaded in the two
lanes (Fig 1, Panel C, D).
DOR expression on equine sperm cells
The indirect immunofluorescence approach and the use
of the synthetic tripeptide analogue of the DOR antago-
nist DMT-TIC helped us in the subcellular localization of
Figure 1 Western blot for DOR in equine spermatozoa (A) proteins 
from ejaculated sperm cells were subjected to gradient 4-12% SDS-
polyacrylamide gel and immunoblotted with rabbit anti DOR antise-
rum. Two bands of 50 and 65 kDa were observed (arrows). (B) negative 
control: blot containing proteins from ejaculated sperm cells was incu-
bated with a solution of the primary antibody adsorbed with a molar 
excess of the immunizing peptide. (C and D) same filters re-blotted 
with rabbit anti β-actin as loading control. Results shown are represen-
tative of three separate experiments.
~65 kDa
~50 kDa
A B
~42 kDa
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DOR in equine spermatozoa. With both assays DOR
appears exclusively localized in the mid piece of the
sperm tail (Fig. 2, Panel A and B). Negative controls dem-
onstrate the specificity of fluorescent signals (Fig 2, Panel
C and D).
Effects of DOR agonist/antagonist on motility
The agonist DPDPE and 10-7 M naltrindole immediately
decrease the percentage of motile sperm cells (p < 0.001;
Fig 3, Panel A) after the addition to the culture medium.
The agonist keeps the decrease of the motile cells at T30,
T90 and T180 min. At T90 min the biphasic effect of the
antagonist is noticeable: at 10-5 M it reduces the number
of motile cells (p < 0.001; Fig. 3, Panel A) wherease at 10-7
M these cells are increased (p < 0.05; Fig. 3, Panel A). At
T180 min the biphasic effect is also clear: the reduction of
the number of motile sperm cells occurs at 10-4 M and 10-
5 M (p < 0,001) whereas at 10-6 M and 10-7 M the increase
is visible (p < 0,05; Fig. 3, Panel A).
Effects of DOR agonist/antagonist on progressive motility
Immediately after the addition to the culture medium,
DPDPE induces a statistically significant reduction in the
percentage of cells with progressive motility at all concen-
trations tested (p < 0.001; Fig. 3, Panel B). The antagonist
naltrindole at 10-4 M, 10-5 M and 10-7 M also decreases
the number of progressive spermatozoa compared to the
control (p < 0.001; Fig. 3, Panel B).
After 90 min of incubation the DOR agonist induces an
increase of the percentage of progressive motile cells (p <
0,001) compared to the control; after the same time of
incubation only 10-6 M and 10-7 M naltrindole increase
the progressive motile cells (Fig. 3, Panel B). At T180 min
no statistically significant difference is recordable for the
agonist compared to the control, except at10-5 M; only the
highest concentrations of the antagonist (10-4 M and 10-5
M) still reduce the number of progressive cells (p < 0.001;
Fig. 3, Panel B).
Effects of DOR agonist/antagonist on average path velocity 
(VAP), curvilinear velocity (VCL), straight line velocity (VSL)
Naltrindole 10-4 M is the only concentration of the antag-
onist able to modify VAP, VCL, VSL (Table 1), the agonist
at all the concentrations tested doesn't induce a statisti-
cally significant variation of the above cited motility
parameters (Table 1).
Effects of DOR agonist/antagonist on capacitation, AR and 
viability
Cells recorded as dead have not been assessed for their
CTC staining pattern. The addition of naltrindole to the
culture medium induces, after 4.5 h of incubation, a sta-
tistical significant increase of the percentage of capaci-
tated sperm cells when added at the concentration of 10-4
M (p < 0.05).
DPDPE at 10-7 M decreases the percent of capacitated
sperm cells (p < 0.01) as well as naltrindole at 10-5 M (p <
0.05) and 10-6 M (p < 0.01) (Fig 4, Panel A).
The DOR antagonist induces an increase of the per-
centage of AR sperm cells at 10-4 M and 10-7 M (p < 0.001;
Fig 4, Panel B); the same increase is observed after the
addition of 10-6 M DPDPE, while 10-5 M and 10-7 M sig-
nificantly decrease the number of AR spermatozoa (p <
0.01 and p < 0.05 respectively; Fig. 4, Panel B).
Both 10-6 M and 10-7 M DPDPE increase the number of
dead sperm cells after 4.5 h of incubation (p < 0.05 and p
< 0.001; Fig. 4, Panel C). The antagonist shows a biphasic
effect on sperm viability; at 10-4 M and 10-6 M a reduction
in the number of dead sperm cells is observed (p < 0.01,
Figure 2 Localization of DOR and evaluation of mitochondrial ac-
tivity in equine sperm cells by fluorescence and confocal laser 
scanning microscopy. (A) Reactivity staining (green fluorescence) de-
tected by the rabbit anti-DOR antibody is observed exclusively on the 
mid piece of the sperm tail; sperm cells were counterstained by Evans 
blue to visualize sperm morphology. Picture was captured by Nikon 
coolpix 990 digital camera. (B) The highly selective fluorescent tripep-
tide analogue of the DOR antagonist DMT-TIC detected DOR on the 
same sperm region; image captured by confocal laser scanning micro-
scope. (C), (D) negative controls for the antibody and the fluorescent 
tripeptide: in (C), the primary antibody was omitted, only the second-
ary antibody-FITC conjugated was employed; in (D) spermatozoa were 
incubated in the presence of 0.2 μmol l-1 naltrindole to block binding 
sites for the tripeptide. (E) The mid piece of an equine sperm cell con-
taining active mitochondria was intensively labelled by MitoTracker or-
ange (arrow), the cell with inactive mitochondria was only faint 
coloured in the same region (double arrow). Scale bars, 9.0 μm.
A
C D
B
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Figure 3 Dose dependent effects of naltrindole and DPDPE on total and progressive equine sperm cell motility. Panel A: total equine sperm 
cell motility affected by different concentrations of DPDPE and naltrindole at T 0, T 30 min, T 90 min and T 180 min. Panel B: progressive equine sperm 
cell motility affected by different concentrations of DPDPE and naltrindole at T 0, T 30 min, T 90 min and T 180 min. Data are reported as mean ± SD, 
n = 6. The statistical analysis conducted by Chi square test, after comparison with the control condition at the same time point, was considered sig-
nificant for p < 0.05. b = p < 0.05 and c = p < 0.001. Nal-4 = 10-4 M naltrindole; Nal-5 = 10-5 M naltrindole; Nal-6 = 10-6 M naltrindole; Nal-7 = 10-7 M 
naltrindole; DPDPE-5 = 10-5 M DPDPE; DPDPE-6 = 10-6 M DPDPE; DPDPE-7 = 10-7 M DPDPE.
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Fig. 4, Panel C) whereas at 10-7 M an increase in dead
sperm cells occurs (p < 0.01).
Effects of DOR agonist/antagonist on mitochondrial 
activity
Naltrindole at 10-4 M (p < 0.05) and 10-5 M (p < 0.01)
induces a statistical significant decrease of the percent of
sperm cells with active mitochondria (Fig. 4, Panel D). On
the contrary naltrindole at 10-7 M induces an increase (p
< 0.01) in the percent of spermatozoa with active mito-
chondria. No statistically significant effects are induced
by DPDPE at the concentrations used in this work. In this
study the MitoTracker Orange CMTM Ros has been uti-
lized for the first time on equine sperm cells and it proved
to be efficacious for the evaluation of mitochondrial
activity. It showed a strong red colour in the mid piece of
the tail corresponding to active mitochondria while a
faint red colour in the same region, appeared when mito-
chondria were inactive (Fig. 2, Panel E).
Discussion
In this paper DOR has been characterized in equine sper-
matozoa by both a molecular and a functional approach.
The results discussed showed: 1) the presence of DOR in
equine sperm cells; 2) its subcellular localization on
equine spermatozoa; 3) the relationship between its stim-
ulation by specific agonist/antagonist at different concen-
trations and some parameters that characterize the
physiology of the mammalian spermatozoon such as via-
bility, motility, capacitation, AR and mitochondrial activ-
ity.
The delta receptor immunoreactivity following SDS/
PAGE appeared as a doublet of approximately 65 and 50
kDa molecular mass bands according with previously
reports in other species with slightly differences probably
due to the different tissues investigated [36-38]. In human
sperm cells Agirregoitia et al., [12] found a unique 50 kDa
band while in the brain cortex they found two additional
bands of 70 and 35 kDa thus confirming that DOR could
be differently expressed in different tissues. The molecu-
lar masses evidenced for DOR could arise from post
translational modifications of the protein as well as from
different transcriptional isoforms of the gene. Further
studies are required to clarify this topic.
Immunofluorescence experiments showed that DOR
was exclusively localized in the mid piece of the equine
sperm tail. This result underlines the involvement of
DOR in the physiology of the equine sperm cell; indeed
our functional experiments demonstrated that the recep-
tor actively participate in the modulation of motility and
in those membrane modifications such as capacitation
and AR that make the spermatozoon fertile. The localiza-
tion of DOR in mid piece of the tail is consistent, in the
equine species, with the presence of L-type voltage oper-
ated calcium channels [39] and mitochondria in the same
cellular district.
Capacitation, AR and motility are calcium dependent
events, intracellular calcium increase is due to the
entrance of the ion from membrane channels or to its
mobilization from intracellular stores such as mitochon-
dria. Our results evidence a clear effect of DOR on the
Table 1: Dose dependent effects of naltrindole and DPDPE on VAP, VCL and VSL.
Control Nal-4 Nal-5 Nal-6 Nal-7 DPDPE-5 DPDPE-6 DPDPE-7
VAP at T0min 128,44 ± 27,21 171,24 ± 27,55b 151,12 ± 39,52 123,28 ± 18,90 115 ± 30,04 126,54 ± 31,81 120,34 ± 27,60 125,12 ± 32,97
VAP at T30min 132,46 ± 10,84 115,56 ± 14,79 124,3 ± 15,68 129,02 ± 15,65 126,98 ± 16,04 129,08 ± 15,18 134,92 ± 12,80 128,16 ± 11,71
VAP at T90min 127,84 ± 13,70 106,92 ± 25,54 112,38 ± 24,14 126,36 ± 10,56 125,34 ± 10,34 127,56 ± 9,61 126,26 ± 12,67 128,52 ± 13,48
VAP at T180min 99,04 ± 23,63 79,4 ± 19,07 98,28 ± 20,09 113,92 ± 15,14 123 ± 9,89 106,46 ± 20,46 104,56 ± 24,45 123,92 ± 15,36
VCL at T0min 224,44 ± 39,23 323,38 ± 55,37b 277,9 ± 81,77 208,74 ± 21,11 203,9 ± 32,63 218,02 ± 37,39 209,5 ± 30,32 213,32 ± 37,24
VCL at T30min 222,9 ± 20,34 231,2 ± 24,26 227,84 ± 27,32 211,44 ± 19,12 215,04 ± 24,88 223,02 ± 14,68 225,68 ± 19,38 214,76 ± 20,07
VCL at T90min 228,26 ± 28,49 218,78 ± 46,64 217,68 ± 21,71 215,78 ± 14,78 213,68 ± 16,39 223,14 ± 22,74 215,84 ± 16,97 220,42 ± 24,51
VCL at T180min 194,44 ± 37,31 171,7 ± 31,75 199,5 ± 23,51 205,56 ± 25,53 215,14 ± 13,77 200,12 ± 30,24 191,96 ± 31,67 217,86 ± 19,16
VSL at T0min 78,06 ± 17,08 81,06 ± 3,27 79,4 ± 10,19 73,58 ± 15,48 68,86 ± 13,72 78,5 ± 21,10 71,74 ± 17,48 76,3 ± 22,68
VSL at T30min 83,5 ± 10,45 55,34 ± 9,12c 68,96 ± 24,11 78,42 ± 18,72 74,14 ± 15,63 75,54 ± 16,42 86,32 ± 15,94 77,5 ± 15,98
VSL at T90min 72 ± 11,92 49,76 ± 8,92a 59,86 ± 28,67 75,12 ± 17,08 73 ± 11,25 81,02 ± 11,78 77,16 ± 17,53 81,66 ± 17,41
VSL at T180min 59,94 ± 14,14 37,66 ± 10,00b 54,02 ± 20,57 66,76 ± 13,58 75 ± 11,88 67,82 ± 19,68 69,32 ± 23,43 76,84 ± 15,94
Table shows the effects of different concentrations of DPDPE and naltrindole at T 0, T 30 min, T 90 min and T 180 min. Data are reported as mean ± SD, 
n = 6. The statistical analysis conducted by one way-ANOVA test, after comparison with the control condition at the same time point, was considered 
significant for p < 0.05. a = p < 0.01; b = p < 0.05; c = p < 0.001. Nal-4 = 10-4 M naltrindole; Nal-5 = 10-5 M naltrindole; Nal-6 = 10-6 M naltrindole; Nal-7 = 
10-7 M naltrindole; DPDPE-5 = 10-5 M DPDPE; DPDPE-6 = 10-6 M DPDPE; DPDPE-7 = 10-7 M DPDPE.Albrizio et al. Reproductive Biology and Endocrinology 2010, 8:78
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Figure 4 Dose dependent effects of naltrindole and DPDPE on capacitation, AR, vitality and mitochondrial activity: Different concentrations 
of DPDPE and naltrindole affect the number of capacitated (Panel a), AR (Panel B), dead (Panel C) equine sperm cells and those with active mitochon-
dria (Panel D) after 4.5 h of incubation. Data are reported as mean ± SD, n = 6. The statistical analysis conducted by Chi square test, after comparison 
with the control condition at the same time point, was considered significant for p < 0.01. a = p < 0.01; b = p < 0.05 and c = p < 0.001. Nal-4 = 10-4 M 
naltrindole; Nal-5 = 10-5 M naltrindole; Nal-6 = 10-6 M naltrindole; Nal-7 = 10-7 M naltrindole; DPDPE-5 = 10-5 M DPDPE; DPDPE-6 = 10-6 M DPDPE; DP-
DPE-7 = 10-7 M DPDPE.
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above cellular events indirectly showing a modulative
effect on intracellular calcium increase.
The two molecular techniques employed let us hypoth-
esize that different post translational modifications or
transcriptional variants of DOR together with its subcel-
lular localization are species specific.
Functional experiments with the use of DOR agonist
and antagonist showed that the receptor is actively
involved in modulating the kinetic of equine spermato-
zoa. In this study we employed the same concentration of
DPDPE and naltrindole utilized by Agirregoitia et al. [12]
in humans to verify whether the different molecular pat-
tern observed in the horse can be responsible for a differ-
ent pharmacological response of the receptor. The effect
exerted by the employed ligands is both immediate and at
long term, depending on their dose and on the specific
kinetic parameter analyzed. On motility, we observed a
reduction of the percent of motile and progressive sperm
cells immediately after the addition of the agonist (10-7 M
DPDPE). The same effect was observed with higher con-
centrations of DPDPE on the percent of progressive cells.
The antagonist have the same effect causing a dose-
dependent decrease in the percent of progressive cells
compared with the control. After 180 min of incubation
the agonist kept on reducing total sperm motility,
whereas the antagonist naltrindole showed an opposite
dose dependent effect; indeed motility was decreased at
higher concentration (10-4 M and 10-5 M) and increased
at the lowest one (10-7 M). The same pattern was shown
at 10-7 M naltrindole on progressive cells after 180 min
even if the increase induced was not statistically signifi-
cant probably due to the high standard deviation
recorded. Our data support the general concept of the
biphasic dose dependent effect displayed by other opioid
antagonists [40,41] and confirm previous observations
made by our group on MOR [10,42-44]. Our results con-
cerning the progressive motility of the equine sperm cells
are not totally in agreement with those reported by Agir-
regoitia et al. in humans [12], infact, they did not observe
any effect induced by DPDPE at any concentration; add-
ing 10-4M naltrindole, the unique concentration tested
without the association of DPDPE, they found an initial
decrease in motility that was restored 3.5 h after the addi-
tion.
Other parameters characterized by the CASA system
were VAP, VCL, VSL and only 10-4 M naltrindole was able
to significantly influence some of these motility descrip-
tors. It is interesting to note that at this concentration it
induced a decrease, after 180 min, in VSL and a statisti-
cally significant increase in the percent of capacitated and
AR cells . These results well correlate with the physiology
of the kinetic changes occurring to prepare the spermato-
zoon to the AR onset. The initial increase of the VSL
required for sperm cell progression in the female genital
tract, is followed by a decrease of the same parameter due
to energy depletion after 180 min. This finding is in
agreement with a decrease in the percent of sperm cells
with active mitochondria observed 4.5 h after incubation
(Fig 4). It is also interesting to note that 10-4 M naltrindole
is capable of preserving sperm vitality until 4.5 h of incu-
bation.
Among the concentrations of antagonist utilized, 10-7
M increased the number of AR cells and also that of dead
cells, even if the percent of spermatozoa with active mito-
chondria was increased. This let us suppose that different
DOR antagonist concentrations act eliciting different
intracellular pathways. The results concerning these spe-
cific parameters of the sperm functionality confirm again
the biphasic effect showed by high/low concentrations of
the DOR antagonist. Naltrindole could be a versatile
compound to be used both for in vitro fertilization (IVF)
and artificial insemination (AI) it could be employed at
high concentration (10-4 M) in IVF protocols because
capacitation, AR and viability of spermatozoa are
improved, whereas at low concentration (10-7 M) it could
be more effective for AI, being able to enhance total and
progressive motility and the number of cells with active
mitochondria.
The capability of reducing the occurrence of AR can be
important in the clinical practice, since the acrosome
must remain intact before and during the transit of the
sperm to the isthmus until the binding to the zona pellu-
cida has been accomplished. Early acrosome reactions
render sperm infertile, and therefore, preserving
acrosome integrity before AI is important.
Conclusions
In conclusion in this study we identified DOR in equine
spermatozoa. This result supports the idea that gametes
could be a potential target site for endogenous opioids
because their specific receptors have been detected both
on spermatozoa [10-12] and oocytes [44].
We have also analyzed the effects of DOR activation in
the presence of specific agonist/antagonist compounds
thus contributing to deepen the knowledge of the equine
sperm cell physiology.
We have shown that the DOR antagonist naltrindole
can be utilized to modulate specific physiological equine
sperm characteristics according to the dose. Low concen-
trations positively modulate sperm motility; on the con-
trary high concentrations show the opposite effect.
Moreover low concentrations negatively affect capacita-
tion, AR and viability while the opposite effect is exerted
by high concentrations. We have also observed a low effi-
cacy of the DOR agonist DPDPE in influencing the same
parameters at the used concentrations. In the light of
these evidences we can consider naltrindole an eclectic
agent capable of different effects on equine sperm cell.Albrizio et al. Reproductive Biology and Endocrinology 2010, 8:78
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These results could have important repercussions on
mammalian reproduction and in the economic manage-
ment of the equine breeding, since the DOR antagonist
naltrindole represents a new compound to be used for
the improvement of equine semen for AI and IVF.
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